Theodore Hong
Harvard University
H-index: 67
North America-United States
Top articles of Theodore Hong
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Abstract A036: Quantitative molecular imaging of pancreatic tumor fibrosis for evaluation of response to neoadjuvant therapy: Pre-clinical and first-in-human application of … | Cancer Research | Shadi A Esfahani Hua Ma Shriya Krishna Sergey Shuvaev Arvin Hajmirzaian | 2024/1/16 |
Alliance A022101: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer—Evaluating radiation … | Kathryn Hitchcock Paul Bernard Romesser Qian Shi Jesse G Dixon Sepideh Gholami | 2024/1/20 | |
Abstract B106: Spatially-constrained optimal transport interaction analysis reveals therapy-associated remodeling in the pancreatic cancer microenvironment | Cancer Research | Carina Shiau Jingyi Cao Mark T Gregory Dennis Gong Xunqin Yin | 2024/1/16 |
Colorectal cancer metastatic dMMR immuno-therapy (COMMIT) study: A randomized phase III study of atezolizumab (atezo) monotherapy versus mFOLFOX6/bevacizumab/atezo in the first … | Michael J Overman Greg Yothers Samuel A Jacobs Hanna Kelly Sanoff Deirdre J Cohen | 2024/1/20 | |
Understanding radiation and immunotherapy induced cell state shifts in the pancreatic tumor microenvironment | Cancer Research | Milan Parikh Ryan Park Aparna R Parikh Julie L Koenig Leon Pappas | 2024/3/22 |
ALLIANCE A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical … | medRxiv | Janet Alvarez Qian Shi Arvind Dasari Julio Garcia-Aguilar Hanna Sanoff | 2024 |
Initial safety assessment of the endoscopically injected oncolytic virus OBP-301 in medically inoperable esophageal cancer: NRG-GI007. | Geoffrey Yuyat Ku Jennifer Moughan Terence Marques Williams Prasad S Adusumilli Makoto Nishimura | 2024/1/20 | |
Alliance for Clinical Trials in Oncology (Alliance) trial A022101/NRG-GI009: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited … | BMC cancer | Kathryn E Hitchcock Eric D Miller Qian Shi Jesse G Dixon Sepideh Gholami | 2024/2/13 |
NRG-GI008: Colon adjuvant chemotherapy based on evaluation of residual disease (CIRCULATE-NORTH AMERICA). | Christopher Hanyoung Lieu Guan Yu Scott Kopetz Shannon L Puhalla Peter C Lucas | 2024/1/20 | |
Severe Lymphopenia During Chemoradiation Therapy for Esophageal Cancer: Comprehensive Analysis of Randomized Phase 2B Trial of Proton Beam Therapy Versus Intensity Modulated … | International Journal of Radiation Oncology* Biology* Physics | Xin Wang Peter SN van Rossum Yan Chu Brian P Hobbs Clemens Grassberger | 2024/2/1 |
Phase II results of circulating tumor DNA as a predictive biomarker in adjuvant chemotherapy in patients with stage II colon cancer: NRG-GI005 (COBRA) phase II/III study. | Van K Morris Greg Yothers Scott Kopetz Shannon L Puhalla Peter C Lucas | 2024/1/20 | |
SBRT with ipilimumab and nivolumab to metastatic MSS colorectal and pancreatic cancer: A pooled analysis of four prospective phase II trials. | Hannah Johnson Roberts Jessica Seidenberg Beow Y Yeap Julie L Koenig Aparna Raj Parikh | 2024/1/20 | |
Portal Vein or Superior Mesenteric Vein Thrombosis with Dose-Escalated Radiation for Borderline or Locally Advanced Pancreatic Cancer | Journal of Gastrointestinal Surgery | Alicia C Smart Andrzej Niemierko Jennifer Y Wo Cristina R Ferrone Kenneth K Tanabe | 2023/11 |
Predicting severity of radiation induced lymphopenia in individual proton therapy patients for varying dose rate and fractionation using dynamic 4-dimensional blood flow … | International Journal of Radiation Oncology* Biology* Physics | Lucas McCullum Jungwook Shin Stella Xing Chris Beekman Jan Schuemann | 2023/8/1 |
DNA Damage by Radiopharmaceuticals and Mechanisms of Cellular Repair | Yousef Khazaei Monfared Pedram Heidari Samuel J Klempner Umar Mahmood Aparna R Parikh | 2023/12/12 | |
Molecular Mechanisms of Intratumoral Nerve Recruitment and Perineural Invasion Elucidated with Spatial Transcriptomics and CRISPR Activation | International Journal of Radiation Oncology, Biology, Physics | WL Hwang J Su C Shiau PL Wang JA Guo | 2023/10/1 |
Neoadjuvant therapy followed by surgical resection is safe and effective in elderly patients with pancreatic ductal adenocacinoma: A propensity score-matching analysis | HPB | M Qadan GL Qiao L Bolm KD Lillemoe CF Castillo | 2023/1/1 |
Phase II/III study of circulating tumor DNA as a predictive biomarker in adjuvant chemotherapy in patients with stage II colon cancer: NRG-GI005 (COBRA). | Van K Morris Greg Yothers Scott Kopetz Samuel A Jacobs Peter C Lucas | 2023/2/1 | |
Tolerability, attrition rates, and survival outcomes of neoadjuvant FOLFIRINOX for nonmetastatic pancreatic adenocarcinoma: intent-to-treat analysis | Journal of the American College of Surgeons | Zhi Ven Fong Fidel Lopez Verdugo Carlos Fernandez-del Castillo Cristina R Ferrone Jill N Allen | 2023/6/1 |
Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Cancer Cells in Locally Advanced … | Clinical Cancer Research | Yves Boucher Jessica M Posada Sonu Subudhi Ashwin S Kumar Spencer R Rosario | 2023/4/14 |
